Sanara Ventures, the incubator launched by pharmaceutical company Teva and electronics manufacturer Philips, has revealed some of its investments to Israeli business newspaper Globes.
The unit has so far invested between $1m and $1.15m in four companies: sensor-based telemedicine technology startup HomeDoc, specialized inhaler developer MeWay Pharma, MGD, a respiratory technology spinout from Sheba Medical Center, and a fourth undisclosed startup.
Sanara was formed in January 2015 with $25m of funding pledged for its graduates over an eight-year period.
Assaf Barnea, CEO of Sanara Ventures, told Globes: “I hope to have a diversified, rich portfolio with the right mix in the most relevant fields, and that we will be a platform that supports ventures through the ups and the downs.
“We have the stamina and financial capability to support ventures: I see us backing the companies, and if Teva or Philips are not interested in any specific company, we can bring other strategic players for joint investments.”